Equities

Cegedim SA

Cegedim SA

Actions
TechnologyTechnology
  • Price (EUR)10.80
  • Today's Change0.00 / 0.00%
  • Shares traded759.00
  • 1 Year change-42.25%
  • Beta0.9874
Data delayed at least 15 minutes, as of Nov 22 2024 10:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cegedim SA is a France-based company that produces and distributes data and services linked to medical information and customer relationship management (CRM) activities for the Sales and Marketing Departments in the Healthcare and Life Sciences sectors. Cegedim is also a manufacturer of medical and para-medical management software, and designs management applications dedicated to the health insurance sector. The Company’s falls into three sectors: Life Sciences which comprises solutions specifically designed for pharmaceutical companies; Healthcare professionals designed for doctors, pharmacists and paramedics, and Healthcare Insurance, which is designed for health insurance providers and for companies of any sectors. The Company operates through Webstar Health and a number of subsidiaries. Cegedim SA is present in approximately 80 countries around the world.

  • Revenue in EUR (TTM)633.98m
  • Net income in EUR2.02m
  • Incorporated1989
  • Employees6.77k
  • Location
    Cegedim SA137 rue d'AguesseauBOULOGNE-BILLANCOURT 92100FranceFRA
  • Phone+33 149092200
  • Fax+33 146034595
  • Websitehttps://www.cegedim.fr
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CGM:PAR since
announced
Transaction
value
Groupe Visiodent SASDeal completed15 Feb 202415 Feb 2024Deal completed-34.94%--
Data delayed at least 15 minutes, as of Nov 22 2024 10:20 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Netgem SA34.23m1.53m38.73m109.0024.331.534.311.130.04560.04561.020.72440.80339.254.46314,055.003.59-3.135.94-5.6669.0956.974.46-4.351.05--0.0588---1.95-3.18400.9321.66115.28-12.94
Coheris SA14.50m3.44m44.35m70.0012.902.358.243.060.60490.60492.553.320.363510,764.003.24201,347.208.631.8515.173.1162.8872.1023.734.091.45--0.22950.005.661.14-31.2428.42-2.7121.67
Nacon SAS167.71m17.01m56.91m1.03k2.760.17640.76940.33940.19070.19071.822.980.34862.044.11--3.644.044.815.1662.1256.7710.459.380.68941.320.315--7.528.2080.079.6821.98--
Bilendi SA62.73m2.80m59.66m416.0023.491.676.880.9510.55550.555513.097.800.794914.613.12150,798.803.365.374.547.4489.3187.994.236.692.0511.440.2805--2.0416.45-28.397.5211.29--
Wallix Group SA31.39m-8.69m67.87m249.00------2.16-1.34-1.344.81--0.5774-241.763.00132,430.40-16.00-11.80-40.26-22.19109.63114.15-27.70-27.540.9041-30.800.4887--19.8619.01-42.19--8.32--
Claranova SE495.70m-11.20m74.60m772.00----124.330.1505-0.2186-0.21868.75-0.17472.0119.6245.48642,098.40-4.79-1.54-11.74-2.9528.5525.07-2.38-0.76820.6063.931.05---2.2313.58-5.66--15.77--
StreamWIDE SA20.36m4.47m77.69m225.0017.083.297.563.821.621.627.398.420.4311--2.42104,400.009.4610.1612.2414.10----21.9520.61----0.3247--10.7523.5822.80--17.81--
Solocal Group SA337.44m-56.33m94.29m2.08k------0.2794-34.62-34.62207.39-188.241.07--6.85162,074.50-17.890.1935--3.4763.3671.53-16.690.2087--0.0914--0.00-10.08-11.71-1,310.40---14.09--
Pullup Entertainment SA187.33m-19.91m145.88m614.0014.220.86822.490.77871.201.2028.8419.650.5697129.914.60305,104.30-5.822.10-8.052.9115.1224.37-10.212.450.9498-2.880.5464---3.498.26-372.21--234.34--
Deezer SA519.36m-39.32m151.94m624.00------0.2926-0.3077-0.30774.06-2.022.46--8.56832,312.50-19.21------18.50---7.81----------7.42--65.61------
Cegedim SA633.98m2.02m152.25m6.77k72.880.53141.730.24020.14820.148246.5220.320.673173.683.6096,320.120.19291.130.31351.8218.9120.730.28661.760.86341.940.534614.9110.955.66-154.37--5.09--
Cnova NV1.06bn-110.03m276.17m1.00------0.2617-0.3187-0.33333.06-1.821.396.6315.471,055,170,000.00-14.86-6.51-93.74-115.9933.4422.08-10.71-4.040.5199-0.44322.28---29.62-11.265.02---4.66--
SideTrade SA47.67m7.06m336.16m398.0048.620.009141.227.054.714.7131.5725,298.410.0013--0.0106152,291.600.0198.220.031213.1573.7470.2114.8211.51--38.020.2036--18.9812.6966.7220.9128.27--
Data as of Nov 22 2024. Currency figures normalised to Cegedim SA's reporting currency: Euro EUR

Institutional shareholders

14.34%Per cent of shares held by top holders
HolderShares% Held
Amiral Gestion SAas of 29 Dec 2023595.35k4.22%
Quaero Capital SAas of 31 Dec 2023377.82k2.68%
HC Capital Advisors GmbHas of 30 Jun 2024266.29k1.89%
Ennismore Fund Management Ltd.as of 31 Dec 2023248.85k1.77%
DNCA Finance SAas of 29 Dec 2023200.00k1.42%
Dimensional Fund Advisors LPas of 07 Nov 2024113.94k0.81%
Adepa Asset Management SAas of 30 Jun 202487.69k0.62%
Mirova SA (Investment Management)as of 30 Aug 202448.83k0.35%
KBC Asset Management NVas of 30 Jun 202444.10k0.31%
G�n�rali Investments Partners SpA SGR (France)as of 28 Feb 202238.00k0.27%
More ▼
Data from 29 Dec 2023 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.